Suchergebnisse - "Uchida, Yoshihito"

PubPharm (106)

51

Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination : A pitfall in antiviral therapy with direct‐acting antivirals

enthalten in: Hepatology Research | 2018

von Kurata, H. | Uchida, Y. | Kouyama, J. | +11

52

"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

53

Nationwide survey for acute liver failure and late-onset hepatic failure in Japan

enthalten in: Journal of gastroenterology | 2017

von Nakao, M. | Nakayama, N. | Uchida, Y. | +12

54

Nationwide survey for acute liver failure and late-onset hepatic failure in Japan

enthalten in: Journal of gastroenterology | 2017

von Nakao, M. | Nakayama, N. | Uchida, Y. | +12

55

Nationwide survey for acute liver failure and late-onset hepatic failure in Japan

enthalten in: Journal of gastroenterology | 2017

von Nakao, M. | Nakayama, N. | Uchida, Y. | +12

56

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis

enthalten in: Journal of gastroenterology | 2017

von Watanabe, K. | Uchida, Y. | Sugawara, K. | +4

57

“Reversi-Type Virologic Failure” Involved in the Development of NS5A-RAVs in Patients with Genotype 1b HCV Carrying No Signature RAVs at Baseline

enthalten in: Hepatology research | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

58

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte–monocyte absorptive apheresis in patients with severe alcoholic hepatitis

enthalten in: Journal of gastroenterology | 2017

von Watanabe, K. | Uchida, Y. | Sugawara, K. | +4

59

“Reversi‐type virologic failure” involved in the development of non‐structural protein 5A resistance‐associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline

enthalten in: Hepatology research | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

60

Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2016

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5